RxDoctor Payments Data

Henry Tam, MD

Family Medicine · Aiken, SCNPI 1306834247

Payments from drug & device makers

$15,456in general payments, 2019–2025

Across 989 payments — averaging $15.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • AbbVie$1K
  • Novo Nordisk$1K
  • Lilly USA, LLC$1K
  • GSK$967
  • Pfizer$776
  • plus $8K from 52 others

What the payments were for

  • Food & beverage$15,34999%
  • Education$1061%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca123$2,272
AbbVie(2 entities)128$1,398
Novo Nordisk53$1,057
Lilly USA, LLC79$1,004
GSK70$967
Pfizer57$776
Boehringer Ingelheim43$725
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC38$565
Novartis32$537
Astellas Pharma US Inc24$483
Amarin Pharma, Inc.34$465
Sanofi-aventis U.S. LLC25$427
Johnson & Johnson19$357
Bayer17$356
Otsuka America Pharmaceutical, Inc.20$348
Amgen(2 entities)23$347
Xeris Pharmaceuticals, Inc.15$290
Phathom Pharmaceuticals, Inc.8$250
Esperion Therapeutics, Inc.14$220
Mannkind Corporation13$206
Exact Sciences12$199
Merck15$190
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)10$186
Takeda Pharmaceuticals U.S.A., Inc.14$184
Kowa Pharmaceuticals America, Inc.9$126
Corcept Therapeutics6$125
Insulet Corporation8$119
Arbor Pharmaceuticals, Inc.9$118
Azurity Pharmaceuticals, Inc.7$107
Vanda Pharmaceuticals Inc.4$96
Nestle Healthcare Nutrition Inc.7$94
Sunovion Pharmaceuticals Inc.5$76
Cequr Corporation2$66
Biohaven Pharmaceutical Holding Company Ltd.4$61
Biohaven Pharmaceuticals, Inc.4$58
Abbott3$52
Teva Pharmaceuticals USA, Inc.3$50
Scilex Pharmaceuticals Inc.3$49
Mylan Specialty L.p.3$46
Eisai Inc.1$44
Viatris Specialty LLC2$41
Adlon Therapeutics L.p.3$41
Embecta Corp.2$32
Nevro Corp.1$28
Zyla Life Sciences, Inc.2$28
Lundbeck LLC2$27
Dexcom, Inc.2$25
Supernus Pharmaceuticals, Inc.1$17
Stryker1$16
BD1$15
Shield Therapeutics Inc1$15
Axsome Therapeutics, Inc.1$15
Currax Pharmaceuticals LLC1$14
Jazz Pharmaceuticals Inc.1$14
Redhill Biopharma Inc.1$12
Amneal Pharmaceuticals LLC1$12
Boston Scientific1$11
Sumitomo Pharma America, Inc.1$1

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,456 in reported general payments places this provider in the 95th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$366,594
Medicare patients
722
Services billed
7,703

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol330$259,177
JanuviaSitagliptin Phosphate229$193,664
OzempicSemaglutide83$101,514
JardianceEmpagliflozin86$87,600
Trelegy ElliptaFluticasone/Umeclidin/Vilanter90$82,901
RybelsusSemaglutide54$77,402
VraylarCariprazine Hcl46$70,320
EliquisApixaban98$64,776
KerendiaFinerenone44$58,874
XareltoRivaroxaban50$46,091
MounjaroTirzepatide39$44,261
MyrbetriqMirabegron42$33,967
TrulicityDulaglutide28$32,065
TradjentaLinagliptin26$29,639
VascepaIcosapent Ethyl28$19,356

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort, Nexium$2,272$296,669391 claims
MerckJanuvia$190$193,664229 claims
Novo NordiskOzempic, Rybelsus$1,057$178,916137 claims
Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat$725$126,545130 claims
GSKTrelegy Ellipta, Breo Ellipta$967$91,607105 claims
AbbVieVraylar, Linzess$1,398$86,94460 claims
Lilly USA, LLCMounjaro, Trulicity$1,004$76,32667 claims
PfizerEliquis$776$64,77698 claims
BayerKerendia$356$58,87444 claims
Johnson & JohnsonXarelto$357$46,09150 claims
Astellas Pharma US IncMyrbetriq$483$33,96742 claims
Arbor Pharmaceuticals, Inc.Edarbyclor$118$10,42026 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Aiken

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →